The Beauty Health (SKIN) Fundamental Analysis: Revenue, Earnings & Valuation

8.39 / 10

Outperform

Fundamental analysis rates SKIN as Outperform with an 8.4/10 score. Key metrics—PB 0.49 (group 1), PS 3.53 (group 2), ROE –2.16% (group 1), and Profit‑MV 0.43 (group 2)—indicates high quality and strong profitability despite a negative ROE.

Analysis Checks(9/10)

PB

Value0.49

Score3/3

Weight20.64%

1M Return27.45%

PS

Value3.53

Score2/3

Weight7.70%

1M Return13.00%

ROA

Value-0.00

Score2/3

Weight2.91%

1M Return4.91%

Profit-MV

Value0.43

Score3/3

Weight18.64%

1M Return26.71%

PB-ROE

Value-0.54

Score3/3

Weight20.64%

1M Return27.45%

ROE

Value-0.02

Score3/3

Weight20.25%

1M Return26.94%

CFOA

Value0.04

Score1/3

Weight0.84%

1M Return1.72%

GPOA

Value0.28

Score2/3

Weight0.61%

1M Return1.22%

NPM

Value-0.16

Score2/3

Weight7.29%

1M Return8.21%

Asset-MV

Value-0.43

Score2/3

Weight0.48%

1M Return0.74%

Is SKIN fundamentally strong?

SKIN scores 8.39/10 on fundamentals and holds a Discounted valuation at present. Backed by its -16.87% ROE, -3.16% net margin, -10.81 P/E ratio, 1.69 P/B ratio, and 65.22% earnings growth, these metrics solidify its Outperform investment rating.